GSK Pharmaceuticals' book value per share India FY 2015-2024

Published by A. Minhas, Jan 3, 2025

In financial year 2024, the book value per share for GSK Pharmaceuticals Limited stood at 105 Indian rupees. This marked a slight increase in the book value for GSK shares compared to the previous year. In financial year 2024, GSK ranked as the leading brand in the private vaccine market and dermatology segment.

Book value per share of GSK Pharmaceuticals Limited across India from financial year 2015 to 2024 (in Indian rupees)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2024

Region

India

Survey time period

FY 2015 to FY 2024

Supplementary notes

One Indian rupee is equal to 0.011 euros and 0.012 U.S. dollars (as of January 2025). 

India's fiscal year starts in April and ends in March. For example, FY 2025 started in April 2024 and ended in March 2025.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Zoetis "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Zoetis

Overview

4

Revenue figures

4

Revenue distribution

4

Competitors

3

Other key data

4

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.